On October 19, Akrikhin celebrates its 85th anniversary. Since 1936, the Company aims to improve life quality of Russian patients.

Today Akrikhin is a leading Russian pharmaceutical manufacturer producing effective, affordable top-quality medicines in socially relevant therapy groups. Akrikhin is a large advanced enterprise with production rates exceeding 100 mln packs of finished drugs annually. The Company has its own R&D Centre, enabling it to issue several new medicines each year. All Akrikhin products are produced in full compliance with international quality standards and GMP (good manufacturing practice).

Through all this period, Akrikhin pursues dynamic development, continuous search of new opportunities, and introduction of innovations to meet present demands and needs of Russian healthcare.

Currently Akrikhin is an expert in general therapy, cardiology, rheumatology, pulmonology, neurology, dermatovenereology, and ophthalmology. Such medicines as Aquadetrim, Akriderm, Bystrum Gel, Venolife, Otrio, etc. are widely known and popular with patients.

The corporate strategy involves improvement of existing products and expansion of production capacities for commercial launch of new innovative medicines, as well as close cooperation with medical and pharmaceutical associations, Russian and international pharmaceutical companies, suppliers and clients.

We thank our patients for their trust in our products and our employees and partners for their professional attitude and indispensable contribution to development of Akrikhin!

In honour of 85th Anniversary of Akrikhin, its president Denis Chetverikov gave a comprehensive interview to the leading sectoral edition, Pharm Vestnik, where he related of the company’s achievements and further plans. Full interview is available here.